Dr. Lyou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2151 N Harbor Blvd
Fullerton, CA 92835Phone+1 714-446-5900
Summary
- Dr. Yung Lyou is an oncologist and clinical researcher at Providence St. Jude Cross Cancer Institute with numerous peer reviewed abstracts and publications. He is also the Oncology Phase 1 clinical trials program lead. Prior to joining Providence St. Jude he was an assistant clinical professor at City of Hope Comprehensive Cancer Center. He is an expert in genitourinary (prostate, bladder, kidney), lung, and gastrointestinal cancers.
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 2014 - 2018- University of California (Irvine)Residency, Internal Medicine, 2012 - 2015
SUNY Upstate Medical UniversityClass of 2012
Certifications & Licensure
CA State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 40 citationsInhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.Yung Lyou, Amber N Habowski, George Chen, Marian L. Waterman
British Journal of Pharmacology. 2017-12-01 - 34 citationsMachine Learning-Based Interpretation and Visualization of Nonlinear Interactions in Prostate Cancer Survival.Richard Li, Ashwin Shinde, An Liu, Scott Glaser, Yung Lyou
JCO Clinical Cancer Informatics. 2020-07-16 - 410 citationsGlobal Reorganization of Replication Domains During Embryonic Stem Cell DifferentiationIchiro Hiratani, Tyrone Ryba, Mari Itoh, Tomoki Yokochi, M. Schwaiger
Plos Biology. 2008-10-07
Journal Articles
- Orbital Metastases from Breast Cancer with BRCA2 Mutation: A Case Report and Literature ReviewYung Lyou, Erin Lin, Case Reports in Oncology
Press Mentions
Breast Cancer: Researchers Say It's OK to Pause Long-Term Treatment for PregnancyDecember 13th, 2022- Prostate Cancer Care Rebounding After COVID-19 DisruptionSeptember 1st, 2020
- Loss, Mutation of NCOR2 Likely Fuels Prostate Cancer Progression, ResistanceDecember 28th, 2021
- Join now to see all
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
